Northwestern University

Grants

Grants per year 1988 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2050

• 43 Not started
• 5542 Active
• 20406 Finished

Grants per year

Search results

• Active

  BEET root juice to reverse functional impairment in PAD: The BEET PAD Trial

  McDermott, M. M., Ho, K. J., Sufit, R. L. & Zhao, L.

  National Institute on Aging

  7/1/22 → 6/30/27

  Project: Research project

  • Peripheral Arterial Disease 100%
  • Nitrites 45%
  • Nitrates 36%
  • Walking 28%
  • Muscles 24%

• Quantum Coherent Applications of Superfluid 3He

  Halperin, W. P.

  National Science Foundation

  7/1/22 → 6/30/25

  Project: Research project

  • aerogels 100%
  • proposals 49%
  • helium 41%
  • dark matter 34%
  • orbitals 28%

• Elucidating cellular mechanisms underlying neurodegeneration

  Opal, P. & Kelleher, N. L.

  National Institute of Neurological Disorders and Stroke

  6/17/22 → 5/31/27

  Project: Research project

  • Giant Axonal Neuropathy 100%
  • Intermediate Filaments 37%
  • Proteins 10%
  • Pathology 8%
  • Ubiquitin-Protein Ligases 7%

• Development of anti-LTBP4 as a biologic to treat Neuromuscular Diseases

  Demonbreun, A. R. & McNally, E. M.

  National Institute of Neurological Disorders and Stroke

  6/16/22 → 5/31/24

  Project: Research project

  • Carrier Proteins 100%
  • Neuromuscular Diseases 80%
  • Duchenne Muscular Dystrophy 48%
  • Lead 28%
  • Muscles 24%

• Optimizing Implementation of Treat-to-Target in Inflammatory Bowel Disease

  Dulai, P. S.

  Pfizer Inc.

  6/16/22 → 6/15/23

  Project: Research project

  • Data Warehousing 100%
  • Patient Reported Outcome Measures 74%
  • Inflammatory Bowel Diseases 64%
  • Endoscopy 60%
  • Mental Health 53%

• Cysteine Depletion-induced Ferroptosis as a Therapeutic Vulnerability in Glioblastoma Temozolomide Resistance

  Cheng, S., Hu, B. & James, C. D.

  National Institute of Neurological Disorders and Stroke

  6/15/22 → 4/30/24

  Project: Research project

  • Ferroptosis 100%
  • Temozolomide 83%
  • Cysteine 67%
  • Glioblastoma 42%
  • Recycling 19%

• Cellular Pathophysiology of Neuronal Na/K-ATPase Dysfunction

  George, A. L. & Thompson, C. H.

  National Institute of Neurological Disorders and Stroke

  6/15/22 → 4/30/27

  Project: Research project

  • sodium-translocating ATPase 100%
  • Neurons 81%
  • Dystonia 38%
  • Membrane Potentials 32%
  • Alternating hemiplegia of childhood 28%

• ENDEAVOR TO STOP NAUSEA/VOMITING ASSOCIATED WITH PREGNANCY (E-SNAP)

  Wisner, K. L., Avram, M. J., Kim, K. A. & Stika, C. S.

  National Institute of Child Health and Human Development

  6/13/22 → 5/31/24

  Project: Research project

  • Mirtazapine 100%
  • Nausea 62%
  • Vomiting 60%
  • Pregnancy 49%
  • Pregnant Women 28%

• Adaptation and Pilot Test of an Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy

  Pack, A. P., Bailey, S. C. & Liebovitz, D. M.

  Merck Sharp & Dohme Corporation

  6/12/22 → 6/11/24

  Project: Research project

• IPA for Liz Platt

  Martin-Harris, B.

  Edward Hines, Jr. VA Hospital

  6/12/22 → 12/31/22

  Project: Research project

  • Deglutition 100%
  • Respiratory Physiological Phenomena 30%
  • Organized Financing 23%
  • Manuscripts 22%
  • Occupational Groups 14%

• Prot #TAK-007-2001: A Phase 2, Open-label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

  Karmali, R.

  PPD Investigator Services, LLC, Takeda Development Center Americas, Inc.

  6/10/22 → 6/10/25

  Project: Research project

• Prot# EP0165: An Open-label, Multicenter, Outpatient Extension Study to Evaluate the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

  Schuele, S. U.

  Parexel, UCB Biopharma SPRL

  6/3/22 → 6/3/25

  Project: Research project

• Prot #CA224-098: A Phase 3, Randomized, Double-blind Study of Adjuvant Immunotherapy with Relatlimab and Nivolumab Fixed-dose Combination versus Nivolumab Monotherapy after Complete Resection of Stage III-IV Melanoma (RELATIVITY 098)

  Chandra, S.

  Bristol-Myers Squibb Company

  6/3/22 → 6/3/25

  Project: Research project

• Investigate MOF regulated epigenetic mechanisms of skin development

  Yi, R. & Wang, D.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  6/3/22 → 4/30/27

  Project: Research project

  • Epigenomics 100%
  • Skin 55%
  • Histone Code 52%
  • Diptera 33%
  • Genetic Dosage Compensation 28%

• New PROTACs Targeting Tissue Transglutaminase in Ovarian Cancer

  Schiltz, G. E.

  U.S. Army Medical Research and Materiel Command

  6/1/22 → 5/31/25

  Project: Research project

  • Ovarian Neoplasms 100%
  • transglutaminase 2 87%
  • Guanosine Triphosphate 61%
  • Neoplasm Metastasis 42%
  • Ascitic Fluid 40%

• GOALI: Fine Particle De-Mixing in Granular Flows

  Lueptow, R. M., Ottino, J. M. & Umbanhowar, P.

  National Science Foundation

  6/1/22 → 5/31/25

  Project: Research project

  • physics 100%
  • computerized simulation 64%

• Measurement of electrostatic potentials at grain boundaries in oxides

  Haile, S. M.

  UChicago Argonne, LLC, Argonne National Laboratory, Department of Energy

  6/1/22 → 8/31/22

  Project: Research project

  • research projects 100%
  • solid oxide fuel cells 94%
  • electrostatics 81%
  • grain boundaries 79%
  • oxides 66%

• Using systems dynamics modeling and implementation research to improve hypertension management in primary care

  Huffman, M. D.

  American Heart Association

  6/1/22 → 5/31/23

  Project: Research project

  • Retention in Care 100%
  • Primary Health Care 70%
  • Hypertension 58%

• Prot #CIP0218: DEXTERITY-SCI: Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation after Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT

  Desai, K. R.

  Mercator MedSystems, Inc.

  6/1/22 → 6/1/25

  Project: Research project

• Exploring the Impact of Gut Neutrophil Heterogeneity on Clinical Response of IBD Patients to anti-TNFα Biologics

  Sumagin, R.

  Kenneth Rainin Foundation

  6/1/22 → 5/31/23

  Project: Research project

  • Biological Products 100%
  • Neutrophils 68%
  • Tumor Necrosis Factor-alpha 61%
  • Certolizumab Pegol 52%
  • Mesalamine 42%

• GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease

  Watterson, D. M.

  National Institute on Aging

  6/1/22 → 5/31/26

  Project: Research project

  • Alzheimer Disease 100%
  • Toxicology 94%
  • Drug Compounding 87%
  • Cytokines 58%
  • Clinical Studies 49%

• Lakeside Conference on Protein Toxins and Effectors 2021

  Satchell, K. J. F.

  National Institute of Allergy and Infectious Diseases

  6/1/22 → 5/31/23

  Project: Research project

  • toxin 100%
  • protein 56%
  • human disease 36%
  • disease cause 13%
  • virulence 12%

• Postsynaptic roles of ankyrins

  Penzes, P., Savas, J. N. & Weiss, C.

  National Institute of Mental Health

  6/1/22 → 3/31/27

  Project: Research project

  • Ankyrins 100%
  • Synapses 30%
  • Dendrites 11%
  • Endocannabinoids 9%
  • Axon Initial Segment 8%

• HIV immune environment impact on pre-eclampsia

  Martinelli, E. & Lorenzo Redondo, R.

  National Institute of Allergy and Infectious Diseases

  6/1/22 → 5/31/24

  Project: Research project

  • Pre-Eclampsia 100%
  • Pregnant Women 81%
  • HIV 69%
  • Placentation 63%
  • Maternal Mortality 57%

• Long-Term Impact of the COVID-19 Pandemic on Self-Management of Chronic Conditions: The C3 Study

  Bailey, S. C., Wolf, M., Arvanitis, M., Curtis, L. M., Lovett, R. M. & Kwasny, M. J.

  National Institute on Aging

  6/1/22 → 3/31/27

  Project: Research project

  • Pandemics 100%
  • Self-Management 84%
  • Public Health 55%
  • Middle Aged 39%
  • Health 38%